Addex Therapeutics Ltd banner

Intrinsic Value

Is APE undervalued or overvalued?

See the intrinsic value estimate for Addex Therapeutics Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

APE Intrinsic Value
LOCKED
Unlock
Monitor APE
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price €2.16
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to APE

Fundamental Analysis

What Addex Therapeutics Does

Pharmaceuticals Health Care

Addex Therapeutics is a drug development company focused on medicines that act on G protein-coupled receptors, especially through a method called allosteric modulation. In plain English, it tries to make small-molecule drugs that fine-tune how receptors in the brain and body work, rather than simply switching them on or off. Its main work is centered on treatments for nervous system and inflammatory diseases, where receptor control can affect symptoms and disease pathways.

Headquarters
Switzerland CH
Employees
3
IPO date
May 22, 2007
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Addex Therapeutics Ltd

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

What is the Intrinsic Value of one APE stock?

The intrinsic value for Addex Therapeutics Ltd (APE) under the Base Case is hidden EUR.

Is APE stock undervalued or overvalued?

Compared with the current market price of 2.157 EUR, the stock appears hidden.

Back to Top